Abstract:LB-115 Mitochondrial malfunction, which can lead to decreased ATP generation through oxidative phosphorylation and altered drug sensitivity, has long been observed in many cancer cells, but the underlying mechanisms remain to be investigated. Here we report the establishment of an inducible cell model in which the mitochondrial respiratory function can be controlled by tetracycline and the use of this system as a tool to investigate on the relationship between mitochondrial respiratory malfunction, redox alterations, and drug sensitivity. A dominant negative form of the DNA polymerase gamma (POLGdn) was expressed in the T-ReX293 tetracycline inducible system. Mitochondrial malfunction was induced by doxocycline, which led to a almost complete suppression of oxygen consumption, caused by a depletion of the mitochondrial DNA-encoded respiratory chain complex I, III, IV, and V components, despite an increase of nuclear encoded complex II subunit proteins. Accompany with this mitochondrial respiratory defect, superoxide generation from the respiratory chain decreased, whereas cellular hydrogen peroxide level increased, as shown by fluorometric detection using hydroethedine and DCF-DA, respectively. The increase in hydrogen peroxide level was further confirmed by using the catalase to eliminate its specific fluorescent signal. Surprisingly, cellular nitric oxide level also increased when mitochondrial respiration was suppressed. The increase in nitric oxide could be inhibited by the NOS inhibitor L-NMMA. Biochemical analyses showed total cellular glutathione content and the expression of glutathione peroxidase (GPX-1) protein were elevated in the mitochondrial defective cells, whereas the levels of SOD1 and SOD2 proteins remained unchanged. These alterations in cellular redox states were associated with significant changes (increase or decrease) in cellular sensitivity to anticancer agents, depending on the mechanisms of action of the specific drugs. Compounds with pro-oxidant property are more effective in killing the cells with increased hydrogen peroxide and nitric oxide. These observations may have clinical implications in selecting proper drug to kill cancer cells with mitochondrial dysfunction.

Redox Homeostasis Protects Mitochondria Through Accelerating ROS Conversion to Enhance Hypoxia Resistance in Cancer Cells.

Hypoxia stabilizes microtubule networks and decreases tumor cell chemosensitivity to anticancer drugs through Egr-1.

Mitochondrial Redox Signaling And Tumor Progression

Mitochondrial Respiration Defects in Cancer Cells Cause Activation of Akt Survival Pathway Through A Redox-Mediated Mechanism

Hypoxia-induced NAD+ Interventions Promote Tumor Survival and Metastasis by Regulating Mitochondrial Dynamics.

Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy

Hypoxia Boosts Aerobic Glycolysis in Carcinoma: A Complex Process for Tumour Development

Oxygen Partial Pressure Plays a Crucial Role in B16 Melanoma Cell Survival by Regulating Autophagy and Mitochondrial Functions.

Overcome radiation resistance in hypoxic cancer cells by inhibition of glycolysis

A Mitochondrial Oxidative Stress Amplifier to Overcome Hypoxia Resistance for Enhanced Photodynamic Therapy.

Mitochondrial Superoxide Anions Induced by Exogenous Oxidative Stress Determine Tumor Cell Fate: an Individual Cell-Based Study

The Effect of Oxidative Phosphorylation on Cancer Drug Resistance

Role of Autophagy in Cancer Development Via Mitochondrial Reactive Oxygen Species

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer

Cytoprotective Role of Heme Oxygenase-1 in Cancer Chemoresistance: Focus on Antioxidant, Antiapoptotic, and Pro-Autophagy Properties

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials

Mitochondrial Respiratory Defects Lead to Significant Alterations in Cellular Redox States and Drug Sensitivity

Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?

Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a Beclin1-dependent way in hepatocellular carcinoma.

Mitochondria Targeting as an Effective Strategy for Cancer Therapy